Brooks Elaine, Freter Susan H, Bowles Susan K, Amirault David
Department of Orthopaedic Surgery, Nova Scotia Health Authority (Central Zone), Halifax, Nova Scotia, Canada.
Geriatric Medicine, Centre for Health Care of the Elderly, Dalhousie University, Nova Scotia Health Authority (Central Zone), Halifax, Nova Scotia, Canada.
Geriatr Orthop Surg Rehabil. 2017 Sep;8(3):151-154. doi: 10.1177/2151458517720297. Epub 2017 Aug 8.
Pain management after elective arthroplasty in older adults is complicated due to the risk of undertreatment of postoperative pain and potential adverse effects from analgesics, notably opioids. Using combinations of analgesics has been proposed as potentially beneficial to achieve pain control with lower opioid doses.
We compared a multimodal pain protocol with a traditional one, in older elective arthroplasty patients, measuring self-rated pain, incidence of postoperative delirium, quantity and cost of opioid analgesics consumed.
One hundred fifty-eight patients, 70 years and older, admitted to tertiary care for elective arthroplasty were prospectively assessed postoperative days 1-3. Patients received either traditional postoperative analgesia (acetaminophen plus opioids) or a multimodal pain protocol (acetaminophen, opioids, gabapentin, celecoxib), depending on surgeon preference. Self-rated pain, postoperative delirium, and time to achieve standby-assist ambulation were compared, as were total opioid doses and analgesic costs.
Despite receiving significantly more opioid analgesics (traditional: 166.4 mg morphine-equivalents; multimodal: 442 mg morphine equivalents; = 10.64, < .0001), there was no difference in self-rated pain, delirium, or mobility on postoperative days 1-3. Costs were significantly higher in the multimodal group ( = 9.15, < .0001). Knee arthroplasty was associated with higher pain scores than hip arthroplasty, with no significant difference in opioid usage.
A multimodal approach to pain control demonstrated no benefit over traditional postoperative analgesia in elective arthroplasty patients, but with significantly higher amounts of opioid consumed. This poses a potential risk regarding tolerability in frail older adults and results in increased drug costs.
由于术后疼痛治疗不足的风险以及镇痛药(尤其是阿片类药物)的潜在不良反应,老年患者择期关节置换术后的疼痛管理较为复杂。有人提出联合使用镇痛药可能有助于以较低的阿片类药物剂量实现疼痛控制。
我们在老年择期关节置换患者中,比较了多模式疼痛方案与传统方案,测量了自评疼痛、术后谵妄的发生率、阿片类镇痛药的消耗量和成本。
158例70岁及以上因择期关节置换入住三级医疗机构的患者在术后第1至3天进行前瞻性评估。根据外科医生的偏好,患者接受传统术后镇痛(对乙酰氨基酚加阿片类药物)或多模式疼痛方案(对乙酰氨基酚、阿片类药物、加巴喷丁、塞来昔布)。比较了自评疼痛、术后谵妄以及达到备用辅助步行的时间,以及阿片类药物总剂量和镇痛成本。
尽管多模式组接受的阿片类镇痛药明显更多(传统组:166.4毫克吗啡当量;多模式组:442毫克吗啡当量;t = 10.64,P <.0001),但术后第1至3天的自评疼痛、谵妄或活动能力并无差异。多模式组的成本显著更高(t = 9.15,P <.0001)。膝关节置换术后的疼痛评分高于髋关节置换术,阿片类药物使用量无显著差异。
在择期关节置换患者中,多模式疼痛控制方法相较于传统术后镇痛并无优势,但阿片类药物消耗量显著更高。这对体弱的老年人的耐受性构成潜在风险,并导致药物成本增加。